StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Piper Sandler Upgrades Myriad Genetics (MYGN) to Neutral
October 20, 2026 10:57 AM
Piper Sandler analyst Dave Westenberg upgraded Myriad Genetics (NASDAQ: MYGN) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Upgrades
